Post-Marketing Surveillance: Hypothetical Problems

  • Judith K. Jones
Part of the NATO Advanced Study Institutes Series book series (NSSA, volume 39)


A special committee of the “Erician Drug Registration Agency” must consider the following problems which relate to the “Post-Marketing” surveillance issue.


Positive Inotropic Effect Lupus Syndrome Suspected Effect Nitrosamine Formation Case Control Surveillance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Jick, H., Walker, A.M. and Spriet-Pourra, C. Post-marketing Follow-up. J Am Med Assoc. 1979; 242: 2310–2314.CrossRefGoogle Scholar
  2. 2.
    Slone, D., Shapiro, S., Miettinen, O.S. Case control surveillance of serious illnesses attributable to ambulatory drug use, in Epidemiological Evaluation of Drugs, edited by Colombo, F., Shapiro, S., Slone D., Tagnoni, G. Littleton, Massachusetts Publishing Sciences Group, Inc. 1977; pp 59–70.Google Scholar

Copyright information

© Springer Science+Business Media New York 1981

Authors and Affiliations

  • Judith K. Jones
    • 1
  1. 1.Division of Drug Experience Office of Biometrics and EpidemiologyBureau of Drugs, Food and Drug AdministrationRockvilleUSA

Personalised recommendations